Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Energy Expenditure in Spastic Diplegia CP
NCT03469999Phase 3Completed
- Sponsor
- Columbia University
- Start
- Dec 2018
- Primary completion
- May 2021
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in cerebral palsy (CP), spastic quadriplegic cerebral palsy (SQCP), sponsored by Columbia University. Started Dec 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)spastic quadriplegic cerebral palsy (SQCP)
Beyond the preview
Go deeper on NCT03469999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469999.